Invention Grant
US07951774B2 Stereochemically defined dipeptide esters of antiviral agents for enhanced ocular treatment 有权
用于增强眼部治疗的抗病毒剂的立体定义二肽酯

Stereochemically defined dipeptide esters of antiviral agents for enhanced ocular treatment
Abstract:
Stereochemically defined dipeptide esters of nucleoside-analogous antiviral agents including acyclovir and ganciclovir are provided. Certain of these stereochemically defined dipeptide esters are found to have unexpectedly enhanced delivery to and uptake by ocular tissues, crossing the blood-ocular barrier more effectively than other stereochemically defined dipeptide esters. For example, (L-Val)-(D-Val)-acyclovir was found to be taken up more effectively into corneal tissue than were underivatized acyclovir, monoesters (L-Val)-acyclovir or (D-Val)-acyclovir, or diester (L-Val)-(L-Val)-acyclovir.
Information query
Patent Agency Ranking
0/0